Veracyte
VCYT
#4008
Rank
NZ$5.00 B
Marketcap
NZ$63.29
Share price
0.21%
Change (1 day)
-21.77%
Change (1 year)

Earnings for Veracyte (VCYT)

Earnings in 2025 (TTM): NZ$42.79 Million

According to Veracyte's latest financial reports the company's current earnings are NZ$0.49 Billion. In 2024 the company made an earning of NZ$39.8 Million, an increase over its 2023 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veracyte from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$42.79 M7.51%
2024 NZ$39.8 M-131.34%
2023 -NZ$0.13 Billion111.42%
2022 -NZ$60.1 Million-55.5%
2021 -NZ$0.14 Billion134.74%
2020 -NZ$57.53 Million190.89%
2019 -NZ$19.78 Million-43.33%
2018 -NZ$34.9 Million-23.78%
2017 -NZ$45.78 Million-3.51%
2016 -NZ$47.44 Million-14.17%
2015 -NZ$55.28 Million15.17%
2014 -NZ$47.99 Million14.15%
2013 -NZ$42.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exact Sciences
EXAS
-NZ$1.61 Billion-4,019.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-NZ$0.7 Billion-1,791.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$58 Million-241.30%๐Ÿ‡บ๐Ÿ‡ธ USA